News: Anand Nambiar appointed as MD at Merck

C-Suite

Anand Nambiar appointed as MD at Merck

The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.

The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.

Read the Economic Times news report here.

Read full story

Topics: C-Suite, Appointments, #Corporate

Did you find this story helpful?

Author

QUICK POLL

What is your top focus area for reinventing work in the hybrid world of work?

How can we prepare for a challenging 2023?

READ our latest issue for tips and suggestions.